Background Alzheimer disease (AD) aggregates in families. Objective To compare the familial aggregation and lifetime risk of AD to the age of 90 years in the first-degree relatives of patients with AD and unrelated controls among Caribbean Hispanics, African Americans, and whites in Washington Heights, Manhattan, New York, NY. Methods Family history of AD and demographic information were obtained from informants of 435 patients with probable or possible AD concerning 1577 siblings and parents and from 1094 controls without dementia concerning 3952 siblings and parents. Results Lifetime risk of AD to the age of 90 years was 25.9% in relatives of patients and 19.1% in relatives of controls. Rate ratio (RR) for AD in relatives of patients comp...
Background. Epidemiologic evidence suggests that African Americans have higher rates of Alzheimer’s ...
IntroductionLittle is known about dementia incidence in diverse populations of oldest-old, the age g...
The primary objective of this thesis was to determine if patients with early onset (<65 years) non-...
Case-control studies of Alzheimer's disease were re-analysed to examine the association of Alzheimer...
Objectives: To reexamine the association between the apolipoprotein E ϵ4 allele (APOE ϵ4) and famili...
Kaplan-Meier risk estimates were generated and evaluated for 1867 first-degree relatives of 338 Alzh...
Objective: To determine whether first-degree relatives of PD patients w...
Background: Alzheimer’s disease (AD) is an international health concern that has a devastating effec...
BACKGROUND:Alzheimer's disease (AD) is an international health concern that has a devastating effect...
OBJECTIVE: To determine whether differences in genetic origin affect the clinical course of Alzheime...
SummaryElderly individuals who lived beyond the age of 90 years without dementia were hypothesized t...
Objective: To compare the incidence rates for AD among elderly African-American, Caribbean Hispanic,...
IntroductionReducing racial/ethnic disparities is a primary objective of the National Alzheimer's Pl...
textabstractWe evaluated age at onset and transmission patterns of Alzheimer's disease (AD) in famil...
The investigation of genetic and other causes of Alzheimer’s disease requires reliable and valid met...
Background. Epidemiologic evidence suggests that African Americans have higher rates of Alzheimer’s ...
IntroductionLittle is known about dementia incidence in diverse populations of oldest-old, the age g...
The primary objective of this thesis was to determine if patients with early onset (<65 years) non-...
Case-control studies of Alzheimer's disease were re-analysed to examine the association of Alzheimer...
Objectives: To reexamine the association between the apolipoprotein E ϵ4 allele (APOE ϵ4) and famili...
Kaplan-Meier risk estimates were generated and evaluated for 1867 first-degree relatives of 338 Alzh...
Objective: To determine whether first-degree relatives of PD patients w...
Background: Alzheimer’s disease (AD) is an international health concern that has a devastating effec...
BACKGROUND:Alzheimer's disease (AD) is an international health concern that has a devastating effect...
OBJECTIVE: To determine whether differences in genetic origin affect the clinical course of Alzheime...
SummaryElderly individuals who lived beyond the age of 90 years without dementia were hypothesized t...
Objective: To compare the incidence rates for AD among elderly African-American, Caribbean Hispanic,...
IntroductionReducing racial/ethnic disparities is a primary objective of the National Alzheimer's Pl...
textabstractWe evaluated age at onset and transmission patterns of Alzheimer's disease (AD) in famil...
The investigation of genetic and other causes of Alzheimer’s disease requires reliable and valid met...
Background. Epidemiologic evidence suggests that African Americans have higher rates of Alzheimer’s ...
IntroductionLittle is known about dementia incidence in diverse populations of oldest-old, the age g...
The primary objective of this thesis was to determine if patients with early onset (<65 years) non-...